Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai
Patent
1984-06-04
1986-05-13
Rollins, Alton D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Silicon containing doai
549214, 549292, 556441, C07F 708, A61K 31695
Patent
active
045887152
ABSTRACT:
Compounds of the formula ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are alkyl or aryl groups, A, B, C and D are non-reactive substituents or two are joined to form an additional ring, and Z is either of the formula Z': ##STR2## wherein R.sup.4 is H, lower alkyl or a cation; or a -6-oxotetrahydropyran-2-yl ring of the formula Z": ##STR3## e.g. 4-hydroxy-6-{2-[2-(methyldiphenylsilyl)phenyl]ethenyl]ethyenyl}-tetrahydro -2H-pyran-2-one, (trans, trans). The compounds inhibit cholesterol biosynthesis and are useful as anti-atherosclerotic agents.
REFERENCES:
patent: 4000265 (1976-12-01), Quilichini
patent: 4255444 (1981-03-01), Oka et al.
patent: 4262013 (1981-04-01), Mistui et al.
patent: 4293496 (1981-10-01), Willard
patent: 4361515 (1982-11-01), Terahara et al.
patent: 4375475 (1983-03-01), Willard et al.
patent: 4420475 (1983-12-01), Damon, II
patent: 4472426 (1984-09-01), Hoffman et al.
Dinner D. L.
Rollins Alton D.
Sandoz Inc.
Sharkin Gerald D.
Vila Richard E.
LandOfFree
Heptenoic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heptenoic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heptenoic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1770212